CrossAssetDataThe Company File
···
OABI

OmniAb, Inc.

OmniAb, Inc. is classed by the SEC under Services-Commercial Physical & Biological Research (industry code 8731), based in Emeryville, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $19 million and a loss of $65 million (its filed statements).

Pre-revenue company Services-Commercial Physical & Biological Research Emeryville, CA filings since 2021 7 of 9 filed, 2 estimated
Ask the desk about OABI → Compare OABI with ABSI → Price chart on TradingView ↗ Full EDGAR file ↗ Watch OABI →

Sector peers: ABSIMXCTNRCMEDP

3.5/10headline grade
vs its business-model standard
1.8/10past 4.8/10present 3.4/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a pre-revenue company: no meaningful revenue on file yet (industry code 8731), so it is read as a pre-revenue company; the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 3.5 out of ten, 7 of 9 metrics filed and 2 estimated: past 1.8 out of ten, present 4.8 out of ten, future 3.4 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 2.1 out of ten. 4 warning events since 2021; the latest 2022-11-07. 21st percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 1.6 out of ten. -14.4% a year over 5 filed years; profitable in 0 of 5. 16th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 2.1 out of ten. CrossAssetData estimate 2.1/10, confidence 35 of 100 (one part). 21st percentile among 12 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 5.8 out of ten. ROE -24%: lost 24¢ per shareholder dollar. Leverage 11%: owes 11¢ per asset dollar. 58th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 2.4 out of ten. bottom 24% of 12 in its family; net margin -347%. 24th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 5.0 out of ten. CrossAssetData estimate 5.0/10, confidence 35 of 100 (one part). 50th percentile among 9 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Room to expand (future): 4.7 out of ten. bottom 47% of 12 in its family for room to expand. 47th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 1.9 out of ten. bottom 19% of 12 in its family for growth drivers. 19th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 4.4 out of ten. bottom 44% of 11 in its family for expectations against reality. 44th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-03-04 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form SCHEDULE 13G/A, 2026-08-14. Filings on record since 2021. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: License and Milestone Revenue 52%, Service 39%, Royalty 5%, X Ploration Revenue 4%. As tagged in its annual report (Form 10-K, filed 2026-03-04).

Who runs it

Foehr, Matthew W (President and CEO); Gustafson, Kurt A (Executive VP, Finance and CFO); Nwachuku, Amechi Ekeke (Chief Operating Officer); Berkman, Charles S (Chief Legal Officer); Bertozzi, Carolyn R (director); Cochran, Jennifer R. (director); Crouse, Steven C. (director); Gotwals, Philip J (director); Higgins, John L (director); Love, Steven (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.